APA 6th Edition

Koršić, M. (2008). Ibandronate (Bonviva®) i.v. - the first bisphosphonate in quartal application. Reumatizam, 55 (2), 107-108. Retrieved from https://hrcak.srce.hr/125283

---

MLA 8th Edition

Koršić, Mirko. "Ibandronate (Bonviva®) i.v. - the first bisphosphonate in quartal application." Reumatizam, vol. 55, no. 2, 2008, pp. 107-108. https://hrcak.srce.hr/125283. Accessed 19 May 2024.

---

Chicago 17th Edition

Koršić, Mirko. "Ibandronate (Bonviva®) i.v. - the first bisphosphonate in quartal application." Reumatizam 55, no. 2 (2008): 107-108. https://hrcak.srce.hr/125283

---

Harvard

Koršić, M. (2008). 'Ibandronate (Bonviva®) i.v. - the first bisphosphonate in quartal application', Reumatizam, 55(2), pp. 107-108. Available at: https://hrcak.srce.hr/125283 (Accessed 19 May 2024)

---

Vancouver

Koršić M. Ibandronate (Bonviva®) i.v. - the first bisphosphonate in quartal application. Reumatizam [Internet]. 2008 [cited 2024 May 19];55(2):107-108. Available from: https://hrcak.srce.hr/125283

---

IEEE

M. Koršić, "Ibandronate (Bonviva®) i.v. - the first bisphosphonate in quartal application", Reumatizam, vol.55, no. 2, pp. 107-108, 2008. [Online]. Available: https://hrcak.srce.hr/125283. [Accessed: 19 May 2024]